Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This clinical trial is focused on determining whether biological signatures of target engagement by a Centella asiatica water extract product administered orally for 6 weeks can be measured in comparison to placebo. This study will also assess the safety and tolerability of the Centella asiatica water extract product.
Epistemonikos ID: 02e12c25c7e5c7620f21682bc27a4402b9d6f244
First added on: May 14, 2024